Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Feb 26;9(16):13101. doi: 10.18632/oncotarget.24572

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Rusdina Bte Ladju 1,2, Devis Pascut 1, Muhammad Nasrum Massi 2, Claudio Tiribelli 1, Caecilia HC Sukowati 1
PMCID: PMC5849200  PMID: 29569656

This article has been corrected: The updated Acknowledgments information is provided below:

ACKNOWLEDGMENTS

RBL is supported by fellowships from the Lembaga Pengelola Dana Pendidikan (LPDP) of the Indonesian Ministry of Monetary, DP by NECTE project of PAR-FSC_2007-13 decree n° 3984/LAVFOR.ISTR/2014 Friuli Venezia Giulia, CHCS fellowship was partially supported by grant NIH U01AA020821. This work was supported by in-house grant from the Fondazione Italiana Fegato, Trieste, Italy, and the Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Original article: Oncotarget. 2018; 9:2951-2961. https://doi.org/10.18632/oncotarget.23359


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES